These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 20946551)
1. Baseline heart rate variability predicts clinical events in heart failure patients implanted with cardiac resynchronization therapy: validation by means of related complexity index. Molon G; Solimene F; Melissano D; Curnis A; Belotti G; Marrazzo N; Marczyk J; Accardi F; Raciti G; Zecchi P Ann Noninvasive Electrocardiol; 2010 Oct; 15(4):301-7. PubMed ID: 20946551 [TBL] [Abstract][Full Text] [Related]
2. Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure. Fantoni C; Raffa S; Regoli F; Giraldi F; La Rovere MT; Prentice J; Pastori F; Fratini S; Salerno-Uriarte JA; Klein HU; Auricchio A J Am Coll Cardiol; 2005 Nov; 46(10):1875-82. PubMed ID: 16286175 [TBL] [Abstract][Full Text] [Related]
3. Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study. Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT JACC Heart Fail; 2015 Sep; 3(9):691-700. PubMed ID: 26277764 [TBL] [Abstract][Full Text] [Related]
4. Value of serial heart rate variability measurement for prediction of appropriate ICD discharge in patients with heart failure. Ten Sande JN; Damman P; Tijssen JG; De Groot JR; Knops RE; Wilde AA; Van Dessel PF J Cardiovasc Electrophysiol; 2014 Jan; 25(1):60-5. PubMed ID: 24118293 [TBL] [Abstract][Full Text] [Related]
5. Plasma tissue inhibitor of matrix metalloproteinase-1 a predictor of long-term mortality in patients treated with cardiac resynchronization therapy. Trucco E; Tolosana JM; Castel MÁ; Batlle M; Borràs R; Sitges M; Guash E; Matas M; Arbelo E; Berruezo A; Brugada J; Mont L Europace; 2016 Feb; 18(2):232-7. PubMed ID: 25883077 [TBL] [Abstract][Full Text] [Related]
6. The effects of cardiac resynchronization treatment on autonomic functions aside from functional status in heart failure. Arslan U; Balcı MM; Kocaoğlu İ; Çimen T; Kalaycı S; Temizhan A Anadolu Kardiyol Derg; 2013 Aug; 13(5):439-45. PubMed ID: 23665985 [TBL] [Abstract][Full Text] [Related]
7. Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial. Lee AY; Kutyifa V; Ruwald MH; McNitt S; Polonsky B; Zareba W; Moss AJ; Ruwald AC Heart Rhythm; 2015 Sep; 12(9):2010-7. PubMed ID: 26025322 [TBL] [Abstract][Full Text] [Related]